Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma

Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Peking University Cancer Hospital & Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials